Track the Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. stock price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are quoted on the CA market, under the supervision of SEDI. Market capitalisation: €3.2m. The latest transaction was reported on 13 August 2026 (11 - Acquisition or disposition carried out privately). Among the most active insiders: Prime Global Investment Fund Ltd.. Every trade is free.
16
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
34Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
About Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp.
Rakovina Therapeutics Inc., formerly Vincero Capital Corp., is a biotechnology company focused on developing innovative cancer treatments. It is listed on the XTSE.